# Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

> **NCT00121810** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 305 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil [CellCept]
- **DRUG:** Corticosteroids
- **DRUG:** Calcineurin inhibitors
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00121810
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 305 (ACTUAL)
- **Last updated:** 2011-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00121810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00121810, "Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00121810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*